Tolerability Issues : The adverse events with the GLP-1-based therapies are primarily gastrointestinal and include nausea, vomiting, constipation, or diarrhea [82], leading to meaningful discontinuation rates that limit real-world effectiveness
Nutrient synergy and musculoskeletal health Bone health research has primarily focused on dietary intake or supplementation of vitamin D and calcium (Ca) due to their relationship with bone mass and fall risk, but several other micronutrients play a role in bone health [e.g., vitamin K, Mg, potassium (K)] (75)
The key inflammatory markers in brain injury include interleukin-1 beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), and interleukin-6 (IL-6)
35 The exact significance of both the former and the latter in therapeutic terms in the management of hyperpigmentation is unknown except what can be gathered from observational studies
Step 5: Dispose of the needle safely
Eat plenty of protein, and fiber GLP-1 medications don't change the fundamentals of healthy eating, Kessler writes, and it's important to be mindful about your food choices on the drugs